PRNewswire

TAIPEI, Oct. 31, 2024 /PRNewswire/ — Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6838.TW) announced today that the company has entered into an exclusive licensing agreement with DÁVI Farmacêutica (“DÁVI”) in Portugal, for exclusive rights to the commercializatio

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: